|
CEP68 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.99680288865056E-15 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
8.96804852601463E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
8.912800E-01 |
| Stage1-vs-Stage3 |
1.671000E-01 |
| Stage1-vs-Stage4 |
2.597400E-03 |
| Stage2-vs-Stage3 |
4.226600E-01 |
| Stage2-vs-Stage4 |
5.528500E-02 |
| Stage3-vs-Stage4 |
1.631960E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.31229999989336E-08 |
| Normal-vs-Asian |
1.95676808090184E-12 |
| Caucasian-vs-AfricanAmerican |
6.123600E-01 |
| Caucasian-vs-Asian |
9.917400E-01 |
| AfricanAmerican-vs-Asian |
6.298200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
2.44249065417534E-15 |
| Male-vs-Female |
3.964200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62503344114384E-12 |
| Normal-vs-Age(81-100Yrs) |
1.242050E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.815200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.564500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.754200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.721600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.303800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.046400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.902980E-03 |
| Classical-VS-Follicular |
1.186600E-01 |
| Classical-VS-Other |
2.337800E-01 |
| Classical-VS-Normal |
3.76809694557778E-13 |
| Tall-VS-Follicular |
1.438780E-01 |
| Tall-VS-Other |
9.765600E-01 |
| Tall-VS-Normal |
1.62525548574877E-12 |
| Follicular-VS-Other |
5.516400E-01 |
| Follicular-VS-Normal |
1.62458935193399E-12 |
| Other-VS-Normal |
4.26900000000119E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62470037423645E-12 |
| N0-vs-N1 |
1.462170E-01 |
|
|
